Showing results (1-10 of 216) with videos related to
Sort By:
Pageof 22
BMC Medical Ethics|May 25, 2026
Ethical challenges of capacity assessment in neurodevelopmental and intellectual disabilitiesJonathan D Santoro, Lilia Kazerooni, Maeve C Lucas, et al.Hypertension (Dallas, Tex. : 1979)|January 14, 2020
Diminished Blood Pressure Profiles in Children With Down SyndromeJonathan D Santoro, Sarah Lee, Michael Mlynash, et al.Journal of Neurology|September 13, 2020
Neurologic complications of Down syndrome: a systematic reviewJonathan D Santoro, Dania Pagarkar, Duong T Chu, et al.Journal of Autism and Developmental Disorders|August 16, 2023
Alternative Diagnoses in the Work Up of Down Syndrome Regression DisorderJonathan D Santoro, Mellad M Khoshnood, Lina Nguyen, et al.Reviews on Recent Clinical Trials|March 9, 2010
The pulse of drug development for Alzheimer's diseaseMichael S RafiiCNS Drugs|June 9, 2016
Improving Memory and Cognition in Individuals with Down SyndromeMichael S RafiiJournal of Alzheimer'S Disease : JAD|August 1, 2014
Preclinical Alzheimer's disease therapeuticsMichael S RafiiCNS Drugs|June 8, 2020
Alzheimer's Disease in Down Syndrome: Progress in the Design and Conduct of Drug Prevention TrialsMichael S RafiiDevelopmental Neurobiology|December 12, 2018
Tau PET Imaging for Staging of Alzheimer's Disease in Down SyndromeMichael S RafiiAlzheimer'S Research & Therapy|December 6, 2014
Pro: Are we ready to translate Alzheimer's disease modifying therapies to people with Down syndrome?Michael S RafiiPageof 22